Fidelity Investments’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $705 | Sell |
121
-284
| -70% | -$1.66K | ﹤0.01% | 5006 |
|
|
2025
Q1 | $3.24K | Sell |
405
-6,058
| -94% | -$48.5K | ﹤0.01% | 4803 |
|
|
2024
Q4 | $69.2K | Buy |
6,463
+694
| +12% | +$7.43K | ﹤0.01% | 3693 |
|
|
2024
Q3 | $74.8K | Buy |
5,769
+1,438
| +33% | +$18.6K | ﹤0.01% | 3589 |
|
|
2024
Q2 | $65K | Buy |
4,331
+386
| +10% | +$5.79K | ﹤0.01% | 3471 |
|
|
2024
Q1 | $110K | Sell |
3,945
-15
| -0.4% | -$420 | ﹤0.01% | 3237 |
|
|
2023
Q4 | $88.7K | Hold |
3,960
| – | – | ﹤0.01% | 3260 |
|
|
2023
Q3 | $82.4K | Hold |
3,960
| – | – | ﹤0.01% | 3165 |
|
|
2023
Q2 | $101K | Buy |
3,960
+38
| +1% | +$973 | ﹤0.01% | 3155 |
|
|
2023
Q1 | $109K | Hold |
3,922
| – | – | ﹤0.01% | 3187 |
|
|
2022
Q4 | $102K | Sell |
3,922
-41
| -1% | -$1.07K | ﹤0.01% | 3207 |
|
|
2022
Q3 | $117K | Sell |
3,963
-25
| -0.6% | -$738 | ﹤0.01% | 3211 |
|
|
2022
Q2 | $162K | Buy |
3,988
+6
| +0.2% | +$244 | ﹤0.01% | 3181 |
|
|
2022
Q1 | $218K | Sell |
3,982
-70,766
| -95% | -$3.87M | ﹤0.01% | 3231 |
|
|
2021
Q4 | $7.33M | Sell |
74,748
-65,971
| -47% | -$6.46M | ﹤0.01% | 2237 |
|
|
2021
Q3 | $35.6M | Sell |
140,719
-1,115
| -0.8% | -$282K | ﹤0.01% | 1567 |
|
|
2021
Q2 | $43.9M | Sell |
141,834
-2,018
| -1% | -$624K | ﹤0.01% | 1502 |
|
|
2021
Q1 | $94.7M | Buy |
+143,852
| New | +$94.7M | 0.01% | 1085 |
|